This inventor holds 65 USPTO granted patents, plus 6 CIPO patents, primarily in Pharmaceutical Innovations (CPC class A61K). Top assignees: Nicox S.a., Italfarmaco Spa, Pierrel Spa. Active years: 1991-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Italy, IT (2008)
- Milan, IT (1998 - 2010)
- Monza, IT (1991 - 2011)
Company Filing History:
61 out of 110 
1 out of 49 
1 out of 25 Years Active: 1991-2011
Areas of Expertise:
Title: The Innovative Journey of Piero Del Soldato in Pharmaceutical Patents
Introduction: Piero Del Soldato is a prominent inventor based in Milan, Italy, renowned for his remarkable contributions to pharmaceutical innovations. With an impressive portfolio of 65 patents, Del Soldato has made significant advancements in drug development, particularly in the treatment of ocular conditions.
Latest Patents: Among his latest innovations are prostaglandin derivatives, specifically prostaglandin nitroderivatives. These compounds are noted for their improved pharmacological activity and enhanced tolerability. Del Soldato's research indicates that these derivatives can be effectively utilized in treating glaucoma and ocular hypertension, offering new hope for patients suffering from these conditions.
Career Highlights: Throughout his esteemed career, Piero Del Soldato has worked with esteemed companies including Nicox S.a. and Pierrel Spa. His experience within these organizations has allowed him to hone his skills in drug discovery and development, leading to impactful inventions that address critical medical needs.
Collaborations: Del Soldato's successful career is also marked by fruitful collaborations with talented colleagues, including Francesca Benedini and Ennio Ongini. These partnerships have fostered a creative environment that encourages innovative thinking and the sharing of expertise, ultimately enhancing the research outcomes and patent filings.
Conclusion: Piero Del Soldato's innovative journey in the pharmaceutical industry demonstrates his commitment to advancing medical science through patentable inventions. His ongoing work with prostaglandin derivatives has the potential to significantly improve treatment options for patients with glaucoma and ocular hypertension, solidifying his legacy as an influential inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile